Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.

Novo Nordisk is teaming up with Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.

GLP-1 RAs are associated with a significant decrease in apnea-hypopnea index among patients with moderate to severe OSA and without diabetes.

The FDA has designated Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara ...

In a US cohort study, hospital inpatient diversity was linked to improved gastrointestinal outcomes in Hispanic and Native American patients.

In patients with Barrett esophagus, EAC significantly increased all-cause mortality, but rates remained elevated after excluding EAC-related deaths.

The FDA is implementing an enhanced review process for food chemicals currently available on the US market, with a particular focus on those that have raised consumer concerns. HealthDay News — The ...

Obesity did not significantly impact colonic endoscopic submucosal dissection results, but overtubes were used more for right ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

House Republicans have proposed cuts to Medicaid funding, which could be devastating to America’s rural hospitals.